
Purines and Pyrimidine Derivatives
Purines have a bicyclic structure, consisting of a six-membered ring fused to a five-membered ring, both containing nitrogen atoms in key positions. Purine derivatives, such as adenine and guanine, are essential for the formation of DNA and RNA. These compounds have therapeutic applications in cancer and viral disease treatments by inhibiting cell replication. Pyrimidines, on the other hand, have a monocyclic six-membered structure with two nitrogen atoms. Their derivatives, such as cytosine, thymine, and uracil, are also essential components of DNA and RNA and are used in chemotherapy and antiviral treatments.
At CymitQuimica, we offer purine and pyrimidine derivatives for research in molecular biology, genomics, and the development of innovative therapies.
Found 8881 products of "Purines and Pyrimidine Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Murexide
CAS:<p>Murexide is used as a complexometric indicator in analytical chemistry for complexometric titrations of calcium, copper nickel and cobalt. It is an inhibitor of dihydrofolate reductase. Further, it acts as an enhancer of sonochemical destruction of chlorinated hydrocarbon pollutants. This Thermo Sci</p>Formula:C8H8N6O6Color and Shape:powder, Dark red or purpleMolecular weight:284.191-((3AR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine-2,4(1H,3H)-dione
CAS:Formula:C12H16N2O6Purity:98%Molecular weight:284.268Thymidine
CAS:Formula:C10H14N2O5Purity:97%Color and Shape:Solid, White powderMolecular weight:242.2314-Chloro-2-(methylthio)-5-nitropyrimidine
CAS:Purity:98%Color and Shape:SolidMolecular weight:205.6199951H-Arg-OH
CAS:<p>M03558 - H-Arg-OH</p>Formula:C6H14N4O2Purity:98%Color and Shape:Crystalline Powder,PowderMolecular weight:174.204(1R)-endo-(+)-Fenchyl alcohol, 96%
CAS:<p>(1R)-endo-(+)-Fenchyl alcohol can be extensively used in daily chemicals such as fair antiperspirant, textile softener and liquid detergent. It can also be esterified by different kinds of organic acids to expand its usage in flavors and fragrances. This Thermo Scientific Chemicals brand product was</p>Formula:C10H18OPurity:96%Color and Shape:Colorless to white to pale cream, Crystals or powder or crystalline powder or fused solid or clear liquid as meltMolecular weight:154.254,6-Dimethyl-2-mercaptopyrimidine, 98% (contains <15%H2O)
CAS:Formula:C6H8N2SPurity:98%Color and Shape:Solid, Slightly pale yellow - Yellow powderMolecular weight:140.22-Chloro-4-ethoxy-6-methyl-pyrimidine
CAS:Formula:C7H9ClN2OPurity:98%Color and Shape:SolidMolecular weight:172.612-Methoxy-pyrimidine-5-carbaldehyde
CAS:Formula:C6H6N2O2Purity:98%Color and Shape:Solid, Beige powderMolecular weight:138.1262-Chloro-9-methyl-7H-purin-8(9H)-one
CAS:Formula:C6H5ClN4OPurity:98%Color and Shape:SolidMolecular weight:184.585-Bromo-4-hydroxy-2-methylpyrimidine
CAS:Formula:C5H5BrN2OPurity:96%Color and Shape:SolidMolecular weight:189.0125-METHOXY-4-METHYLPYRIMIDIN-2-AMINE
CAS:Formula:C6H9N3OPurity:95%Color and Shape:SolidMolecular weight:139.158Alloxan monohydrate, 98%
CAS:<p>Cytotoxic compound that causes oxidative base damage to nuclear DNAAlloxan monohydrate is used as a precursor to prepare purple dye murexide. It is also used in research models to induce diabetes and destroy beta cells. Further, it is a strong oxidizing agent and it forms a hemiacetal with its reduc</p>Formula:C4H2N2O4•H2OPurity:98%Color and Shape:White to cream to yellow to brown to black, Crystals or powder or crystalline powderMolecular weight:160.09 (142.07anhy)Orotic acid monohydrate
CAS:Formula:C5H6N2O5Purity:95%Color and Shape:Solid, White powderMolecular weight:174.1121,3-Dimethylbarbituric acid, 99% (dry wt.), water <6%
CAS:<p>1,3-Dimethylbarbituric acid is used as a catalyst in the Knoevenagel condensation of a series of aromatic aldehydes. It is also used in the synthesis of 5-aryl-6-(alkyl- or aryl-amino)-1,3-dimethylfuro [2,3-d]pyrimidine derivatives and enantioselective synthesis of isochromene pyrimidinedione deriva</p>Formula:C6H8N2O3Purity:99%Color and Shape:White to cream or pale yellow, Crystals or powder or crystalline powderMolecular weight:156.14Fmoc-L-Arg(Pbf)-OH
CAS:<p>M03398 - Fmoc-L-Arg(Pbf)-OH</p>Formula:C34H40N4O7SPurity:96 %Color and Shape:Crystalline PowderMolecular weight:648.78Methyl 5-Bromopyrimidine-2-carboxylate
CAS:Formula:C6H5BrN2O2Purity:98%Color and Shape:SolidMolecular weight:217.0222,4-Diamino-6-hydroxy-5-nitrosopyrimidine
CAS:Formula:C4H5N5O2Purity:97%Color and Shape:SolidMolecular weight:155.1171-(2-Aminopyrimidin-5-yl)ethanone
CAS:Formula:C6H7N3OPurity:98%Color and Shape:SolidMolecular weight:137.1422′-Amino-2′-deoxyuridine
CAS:Formula:C9H13N3O5Purity:97%Color and Shape:Liquid, No data available.Molecular weight:243.2191-Phenylurea
CAS:Formula:C7H8N2OPurity:98%Color and Shape:Solid, White to slightly pale yellow powderMolecular weight:136.1542-Amino-1H-purin-6(7H)-one
CAS:Formula:C5H5N5OPurity:95%Color and Shape:Solid, White - Very pale reddish yellow powderMolecular weight:151.129(S)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione (Linagliptin Impurity)
CAS:Purity:97%Color and Shape:SolidMolecular weight:472.553Caffeine
CAS:Caffeine analytical standard provided with chromatographic purity, to be used as reference material for qualitative determination.Formula:C8H10N4O2Purity:(HPLC) ≥95%Color and Shape:PowderMolecular weight:194.2Theobromine
CAS:Theobromine analytical standard provided with chromatographic purity, to be used as reference material for qualitative determination.Formula:C7H8N4O2Purity:(HPLC) ≥95%Color and Shape:PowderMolecular weight:180.17Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:391.18701171875(S)-Methyl-L-thiocitrulline.Dihydrochloride
CAS:<p>M02076 - (S)-Methyl-L-thiocitrulline.Dihydrochloride</p>Formula:C7H17Cl2N3O2SPurity:>98%Molecular weight:278.194,6-Dimethoxy-2-[phenyl(piperazin-1-yl)methyl]pyrimidine
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:314.38900756835944-(4-Pyrimidin-4-yl-1H-pyrazol-1-yl)benzoic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:266.2600097656251,3-dimethylurea
CAS:Purity:98.0%Color and Shape:Solid, White to almost white crystalline powderMolecular weight:88.11000061035156Urea, mole-ready, A.C.S. reagent grade
CAS:<p>M02656 - Urea, mole-ready, A.C.S. reagent grade</p>Formula:CH4N2OPurity:>99%Color and Shape:SolidMolecular weight:60.055999755859375Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS:<p>Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi</p>Formula:C16H20N2O·HClColor and Shape:White SolidMolecular weight:256.15756Clopidogrel Piperidinylidene Analog ((E)-2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-((2-(3-methoxyphenyl)-2-oxoethyl)thio)piperidin-3-ylidene)acetic acid)
<p>Compounds containing an unfused pyridine ring in the structure, nesoi</p>Formula:C25H26ClNO6SColor and Shape:Pale Yellow SolidMolecular weight:503.11694Pemetrexed Acid (4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formula:C15H14N4O3Color and Shape:Off-White SolidMolecular weight:298.10659Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:<p>Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi</p>Formula:C13H13NOColor and Shape:White Powder ClumpyMolecular weight:199.09971Triacetin
CAS:<p>Esters of acetic acid not elsewhere specified or included</p>Formula:C9H14O6Color and Shape:Colorless Oily LiquidMolecular weight:218.21Ondansetron Related Compound G (3-[(1H-Imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:<p>Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoi</p>Formula:C17H17N3OColor and Shape:White PowderMolecular weight:279.13716Caffeine Related Compound F (1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formula:C7H8N4O2Color and Shape:White Fine PowderMolecular weight:180.06473Pemetrexed Disodium (Disodium N-{p-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamate heptahydrate)
CAS:<p>Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure</p>Formula:C20H19N5Na2O6·7H2OColor and Shape:White PowderMolecular weight:597.18702Methylbenzhydrol (2-Methylbenzhydrol)
CAS:<p>Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoi</p>Formula:C14H14OColor and Shape:White PowderMolecular weight:198.104472-Oxo Clopidogrel (Mixture of Diastereomers) (methyl 2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C16H16ClNO3SColor and Shape:Off-White SolidMolecular weight:337.05394Febuxostat Related Compound D (2-[4-(sec-Butoxy)-3-cyanophenyl]-4-methylthiazole-5-carboxylic acid)
CAS:<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Formula:C16H16N2O3SColor and Shape:Off-White Fine PowderMolecular weight:316.08816Imidazole (1H-Imidazole)
CAS:<p>Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoi</p>Formula:C3H4N2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:68.03745Methyl 2-chloro-β-D-phenylalanine (methyl (R)-2-amino-2-(2-chlorophenyl)acetate, hydrochloride)
CAS:<p>Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoi</p>Formula:C9H10ClNO2·HClColor and Shape:White Off-White SolidMolecular weight:235.01668Allopurinol
CAS:<p>Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure</p>Formula:C5H4N4OColor and Shape:White PowderMolecular weight:136.03851Clopidogrel R-Enantiomer ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C15H15ClN2OSColor and Shape:White Off-White SolidMolecular weight:306.05936Clopidogrel Bisulfate
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C16H16ClNO2S·H2SO4Color and Shape:White Off-White PowderMolecular weight:321.05903Clopidogrel Open Ring Hydrochloride (methyl (S)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C15H16ClNO2S·HClColor and Shape:White Off-White SolidMolecular weight:346.27Tetrahydrothienopyridine Hydrochloride (4,5,6,7-Tetrahydrothieno[3,2-c]pyridine, hydrochloride)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C7H9NS·HClColor and Shape:Off-White SolidMolecular weight:139.04557Pemetrexed Dimethyl Ester (dimethyl (4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate)
CAS:<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Formula:C22H25N5O6Color and Shape:Off-White SolidMolecular weight:455.180482-Oxo R-Clopidogrel (methyl (2R)-2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C16H16ClNO3SColor and Shape:White Off-White SolidMolecular weight:337.05394Ondansetron Related Compound D (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one)
CAS:<p>Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoi</p>Formula:C14H13NOColor and Shape:White Off-White PowderMolecular weight:211.09971Clopidogrel-β-D-glucuronide ((2S,3S,4S,5R,6S)-6-((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C21H22ClNO8SColor and Shape:White Off-White SolidMolecular weight:483.07547Allopurinol Related Compound C (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide)
CAS:<p>Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoi</p>Formula:C6H6N6OColor and Shape:White Off-White Crystalline PowderMolecular weight:178.06031Febuxostat Related Compound E (2-(3-Cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid)
CAS:<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Formula:C15H14N2O3SColor and Shape:White Fine PowderMolecular weight:302.07251Allopurinol Related Compound E (Ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate)
CAS:<p>Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoi</p>Formula:C7H9N3O3Color and Shape:White Off-White PowderMolecular weight:183.06439Pemetrexed Glutamide Trisodium Salt (((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanoyl)-L-glutamic acid, sodium salt)
CAS:<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Formula:C25H28N6O9·3NaColor and Shape:Off-White SolidMolecular weight:556.19178Aspirin
CAS:<p>Ortho-acetylsalicylic acid (aspirin), its salts and esters</p>Formula:C9H8O4Color and Shape:White Colorless SolidMolecular weight:180.04226Acetaminophen
CAS:<p>Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof</p>Formula:C8H9NO2Color and Shape:White PowderMolecular weight:151.06333Pemetrexed Glutamide Sodium ((S)-4-((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanamido)-4-carboxybutanoate, sodium salt)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formula:C25H27N6O9·NaColor and Shape:Blue SolidMolecular weight:555.18395Clopidogrel Ethyl Ester Sulfate (ethyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C17H18ClNO2S·H2O4SColor and Shape:White Off-White SolidMolecular weight:335.07468Clopidogrel N-Oxide (5-((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C16H16ClNO3SColor and Shape:Pale Yellow SolidMolecular weight:337.05394Febuxostat
CAS:<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Formula:C16H16N2O3SColor and Shape:White Off-White PowderMolecular weight:316.08816Clopidogrel Open Ring R-enantiomer (methyl (R)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C15H16ClNO2S·HClColor and Shape:White Off-White SolidMolecular weight:309.05903rac-Clopidogrel Acid N-Oxide (5-(carboxy(2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C15H14ClNO3SColor and Shape:White Off-White SolidMolecular weight:323.03829Allopurinol Related Compound A (3-Amino-4-carboxamidopyrazole Hemisulfate)
CAS:<p>Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoi</p>Formula:C4H6N4OH2O4SColor and Shape:Off-White Yellow PowderMolecular weight:350.31Clopidogrel Thienopyridinium Chloride (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium, chloride)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C16H13ClNO2S·ClColor and Shape:Off-White SolidMolecular weight:318.03555Ondansetron Hydrochloride
CAS:<p>Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoi</p>Formula:C18H19N3O·HCl·2H2OColor and Shape:White Off-White PowderMolecular weight:293.15281Orphenadrine Citrate
CAS:<p>Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoi</p>Formula:C18H23NO·C6H8O7Color and Shape:White Crystalline PowderMolecular weight:269.17796Pemetrexed Sodium 1-Methyl Ester ((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-methoxy-5-oxopentanoic acid, sodium salt)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formula:C21H22N5O6·NaColor and Shape:White Off-White SolidMolecular weight:440.15701Allopurinol Related Compound D (Ethyl 5-amino-1H-pyrazole-4-carboxylate)
CAS:<p>Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure nesoi</p>Formula:C6H9N3O2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:155.06948Pemetrexed Sodium 5-Methyl Ester ((S)-2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-methoxy-5-oxopentanoic acid, sodium salt)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formula:C21H22N5O6·NaColor and Shape:Pale Yellow SolidMolecular weight:440.15701





